Overview


Nanoparticle drug-delivery systems are engineered technologies that use nanoparticles to deliver therapeutic agents in a controlled and targeted manner. Modern drug delivery systems should reduce side effects and doses, as well as dosage frequency. Nanoparticles have been gaining attention recently due to the potential for their use in effective drug delivery. Nanoparticles are a wide range of organic and inorganic materials. Each material is unique and has its own set of properties that can be tailored to specific applications. Nanoparticles have many advantages but also present many challenges. These include but are not limited to, nanotoxicity, biodistribution, accumulation and clearance of nanoparticles from the human body.

Nanoparticle drug-delivery is a new branch that uses nanotechnology to treat and prevent diseases. It makes use of biocompatible nanoparticles, nanorobots, and other nanoscale materials. Many biopolymeric particles can be used for drug delivery, including chitosan (a polymer), xanthum, cellulose and dendrimers. The liposome approach to drug delivery is the most promising and holds the largest share of the global nanoparticle market. There has been a growing interest in certain polymers, which can undergo phase transitions reversible as a consequence of changes in pH and temperature. In recent years, a growing number of nanotherapeutics have reached the clinical phase or been commercialized. NP-based delivery systems have improved pharmacokinetics and biocompatibility. They also target tumors and are more stable.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Nanoparticles for Drug Delivery Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Nanoparticles for Drug Delivery Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Abbvie Inc
  • Aquanova AG
  • BlueWillow biologics
  • Camurus AB
  • Celgene Inc
  • Ceramisphere health pty Limited
  • Cristal Therapeutics
  • CYTIMMUNE Sciences Inc
  • EnColl Corporation
  • EyePoint Pharmaceuticals

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Type

  • Polymeric
    • Dendrimer
    • Polymer micelle
    • Polymersome
    • Nanosphere
  • Lipid Based
    • Liposome
    • Emulsion
    • Nanostructured Lipid Carrier
    • Solid Lipid Nanoparticle
  • Inorganic
    • Silica Nanoparticle
    • Carbon Nanotube
    • Metallic Nanoparticles

By Indication

  • Oncological Diseases
  • Orthopedic Disorders
  • Neurological Diseases
  • Urological Diseases
  • Ophthalmological Diseases
  • Others

End-User

  • Hospitals
  • Specialty Clinics
  • Others

By Region

  •  North America
  •  Europe
  •  Asia-Pacific
  •  Latin America
  •  Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Nanoparticles for Drug Delivery Market By Type, By Indication, By End-User, and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction
    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology
    •   1 Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2 Primary Data
              1.2.1. Key Data from Primary Sources
        3.Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Nanoparticles for Drug Delivery Market Variables, Trends & Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview
    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of Nanoparticles for Drug Delivery Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Nanoparticles for Drug Delivery Market Analysis Tools
    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Nanoparticles for Drug Delivery Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Polymeric
           1.1. Dendrimer
           1.2. Polymer micelle
           1.3. Polymersome
           1.4. Nanosphere
        2. Lipid Based
           2.1. Dendrimer
           2.2. Polymer micelle
           2.3. Polymersome
           2.4. Nanosphere
        3. Inorganic
           3.1. Silica Nanoparticle
           3.2. Carbon Nanotube
           3.3. Metallic Nanoparticles

  • 8.  Nanoparticles for Drug Delivery Market, By Indication Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Oncological Diseases
        2. Orthopedic Disorders
        3. Neurological Diseases
        4. Urological Diseases
        5. Application Overview
        6. Ophthalmological Diseases

  • 9.  Nanoparticles for Drug Delivery Market, By End-User Historical Analysis and Forecast 2023-2031 (USD Million)
    •     
        1. Hospitals
        2. Specialty Clinics
        3. Others

  • 10.  North America Nanoparticles for Drug Delivery Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.  Latin America Nanoparticles for Drug Delivery Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.  Europe Nanoparticles for Drug Delivery Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.  Asia Pacific Nanoparticles for Drug Delivery Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.  Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.  Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 16.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Abbvie Inc
           1.1. Company Overview
           1.2. Product Portfolio
           1.3. Swot Analysis
           1.4. Financial Overview
           1.5. Strategic Overview
        2. Aquanova AG
           2.1. Company Overview
           2.2. Product Portfolio
           2.3. Swot Analysis
           2.4. Financial Overview
           2.5. Strategic Overview
        3. BlueWillow Biologics
           3.1. Company Overview
           3.2. Product Portfolio
           3.3. Swot Analysis
           3.4. Financial Overview
           3.5. Strategic Overview
        4. Camurus AB
           4.1. Company Overview
           4.2. Product Portfolio
           4.3. Swot Analysis
           4.4. Financial Overview
           4.5. Strategic Overview
        5. Celgene Inc
           5.1. Company Overview
           5.2. Product Portfolio
           5.3. Swot Analysis
           5.4. Financial Overview
           5.5. Strategic Overview
        6. Ceramisphere Health Pty Limited
           6.1. Company Overview
           6.2. Product Portfolio
           6.3. Swot Analysis
           6.4. Financial Overview
           6.5. Strategic Overview
        7. Cristal Therapeutics
           7.1. Company Overview
           7.2. Product Portfolio
           7.3. Swot Analysis
           7.4. Financial Overview
           7.5. Strategic Overview
        8. CYTIMMUNE Sciences Inc
           8.1. Company Overview
           8.2. Product Portfolio
           8.3. Swot Analysis
           8.4. Financial Overview
           8.5. Strategic Overview
        9. EnColl Corporation
           9.1. Company Overview
           9.2. Product Portfolio
           9.3. Swot Analysis
           9.4. Financial Overview
           9.5. Strategic Overview
        10. EyePoint Pharmaceuticals
           10.1. Company Overview
           10.2. Product Portfolio
           10.3. Swot Analysis
           10.4. Financial Overview
           10.5. Strategic Overview

  • 17.  Pre and Post COVID-19 Impact
    •   1. Positive Influence On The Healthcare Industry
        2. The Financial Disruption Of The Manufacturing Sector
        3. Impact Of Covid-19 On Emerging Companies
        4. Significant Mandates In The Healthcare Regulations Initiated
      By Administrations
        5. The Overall Economic Slowdown Of The Developing And Developed Nations

  • 18.  FutureWise SME Key Takeaway Points for Client
    •   

Partner

Our Clients